Related references
Note: Only part of the references are listed.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Alessandro Mantovani et al.
DIABETES CARE (2018)
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity
Pierre Bedossa et al.
GUT (2017)
The Increasing Burden of NAFLD Fibrosis in the General Population: Time to Bridge the Gap Between Hepatologists and Primary Care
Marloes van Asten et al.
HEPATOLOGY (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Screening for Nonalcoholic Fatty Liver Disease in Patients With Atherosclerotic Coronary Disease?-In Principle Yes, in Practice Not Yet
Mary E. Rinella
HEPATOLOGY (2016)
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
Claudia Sanna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007-14
F. D. Richard Hobbs et al.
LANCET (2016)
Practical approach to non-alcoholic fatty liver disease in patients with diabetes
F. W. D. Tai et al.
DIABETIC MEDICINE (2015)
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Ethnicity and the diagnosis gap in liver disease: a population-based study
William Alazawi et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2014)
Liver transplantation and non-alcoholic fatty liver disease
Petros Zezos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Non-alcoholic fatty liver disease
Naveed Sattar et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study
Helen Booth et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey
Rosa Gini et al.
BMC PUBLIC HEALTH (2013)
The strength of primary care in Europe: an international comparative study
Dionne Kringos et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2013)
From NAFLD in clinical practice to answers from guidelines
Fabio Nascimbeni et al.
JOURNAL OF HEPATOLOGY (2013)
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project
Paul Avillach et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2013)
Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up
Shira Zelber-Sagi et al.
LIVER INTERNATIONAL (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries
Preciosa M. Coloma et al.
BMJ OPEN (2013)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
Rachel M. Williamson et al.
DIABETES CARE (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Interrelationship between Fatty Liver and Insulin Resistance in the Development of Type 2 Diabetes
Ki-Chul Sung et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project
Preciosa M. Coloma et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Cecilia Soderberg et al.
HEPATOLOGY (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Share Paper
